|
Sign In to gain access to subscriptions and/or personal tools.
|
Update on the Epidemiology and Prognosis of Pediatric Epilepsy
Shlomo Shinnar, MD, PhD
Comprehensive Epilepsy Management Center, Montefiore Medical Center, and the Albert Einstein College of Medicine, Bronx, NY, sshinnar{at}aol.com
John M. Pellock, MD
Comprehensive Epilepsy Institute, Medical College of Virginia/Virginia Commonwealth University, Richmond, VA
Epilepsy is among the most common serious neurologic disorders in childhood. Epidemiologic studies over the past few decades have greatly increased current knowledge of the incidence and prognosis of seizures. Newer epidemiologic studies have used population- or community-based cohorts, and careful attention has been given to etiology and specific epilepsy syndromes, the two most important factors affecting prognosis. Risk of epilepsy is highest in patients with an associated serious neurologic abnormality, such as mental retardation or cerebral palsy. More than two thirds of patients with childhood-onset epilepsy ultimately achieve remission. Of those attaining remission on medications, approximately 70% remain seizure free when medications are discontinued. Mortality is increased in patients with epilepsy, but the increased mortality risk in childhood-onset epilepsy is primarily seen in patients with neurologic abnormalities or intractable epilepsy. Although long-term seizure outcomes are generally favorable, childhood-onset epilepsy is associated with adverse long-term psychosocial outcomes, even in patients attaining remission. This review summarizes recent data on the epidemiology and prognosis of pediatric epilepsy. (J Child Neurol 2002;17:S4S17).
Journal of Child Neurology, Vol. 17, No. 1 suppl,
S4-S17 (2002)
DOI: 10.1177/08830738020170010201

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. R. Asato, R. Manjunath, R. D. Sheth, S. J. Phelps, J. W. Wheless, C. A. Hovinga, J. E. Pina-Garza, L. S. Haskins, and W. M. Zingaro
Adolescent and Caregiver Experiences With Epilepsy
J Child Neurol,
May 1, 2009;
24(5):
562 - 571.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Panayiotopoulos, M. Michael, S. Sanders, T. Valeta, and M. Koutroumanidis
Benign childhood focal epilepsies: assessment of established and newly recognized syndromes
Brain,
September 1, 2008;
131(9):
2264 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Altunbasak, O. Herguner, and H. R. Burgut
Risk Factors Predicting Refractoriness in Epileptic Children with Partial Seizures
J Child Neurol,
February 1, 2007;
22(2):
195 - 199.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Glauser, R. Ayala, R. D. Elterman, W. G. Mitchell, C. B. Van Orman, L. J. Gauer, Z. Lu, and on behalf of the N159 Study Group
Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures
Neurology,
June 13, 2006;
66(11):
1654 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oskoui, R. I. Webster, Xun Zhang, and M. I. Shevell
Factors Predictive of Outcome in Childhood Epilepsy
J Child Neurol,
November 1, 2005;
20(11):
898 - 904.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Serra, M. A. Montenegro, and M. M. Guerreiro
Antiepileptic Drug Withdrawal in Childhood: Does the Duration of Tapering Off Matter for Seizure Recurrence?
J Child Neurol,
July 1, 2005;
20(7):
624 - 626.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Pellock
The Challenge of Neuropsychiatric Issues in Pediatric Epilepsy
J Child Neurol,
August 1, 2004;
19(1_suppl):
S1 - S5.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wu, A. Legido, and F. De Luca
Effects of Valproic Acid on Longitudinal Bone Growth
J Child Neurol,
January 1, 2004;
19(1):
26 - 30.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Pellock
The Challenge of Neuropsychiatric Issues in Pediatric Epilepsy
J Child Neurol,
January 1, 2004;
19(1_suppl):
S1 - S5.
[Abstract]
[PDF]
|
 |
|
|
|